| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci.
|
Nat Genet
|
2010
|
17.38
|
|
2
|
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47.
|
Nat Genet
|
2011
|
7.98
|
|
3
|
DNA methylation profiles in monozygotic and dizygotic twins.
|
Nat Genet
|
2009
|
5.99
|
|
4
|
Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease.
|
Nat Genet
|
2011
|
5.58
|
|
5
|
A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes.
|
Gastroenterology
|
2010
|
5.29
|
|
6
|
Genome-wide association identifies multiple ulcerative colitis susceptibility loci.
|
Nat Genet
|
2010
|
4.65
|
|
7
|
Shotgun metaproteomics of the human distal gut microbiota.
|
ISME J
|
2008
|
3.43
|
|
8
|
Molecular analysis of the gut microbiota of identical twins with Crohn's disease.
|
ISME J
|
2008
|
2.96
|
|
9
|
Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease.
|
Inflamm Bowel Dis
|
2009
|
2.85
|
|
10
|
Metabolomics reveals metabolic biomarkers of Crohn's disease.
|
PLoS One
|
2009
|
2.35
|
|
11
|
Integrated metagenomics/metaproteomics reveals human host-microbiota signatures of Crohn's disease.
|
PLoS One
|
2012
|
1.84
|
|
12
|
Association between variants of PRDM1 and NDP52 and Crohn's disease, based on exome sequencing and functional studies.
|
Gastroenterology
|
2013
|
1.83
|
|
13
|
Deep resequencing of GWAS loci identifies rare variants in CARD9, IL23R and RNF186 that are associated with ulcerative colitis.
|
PLoS Genet
|
2013
|
1.34
|
|
14
|
CD98 expression modulates intestinal homeostasis, inflammation, and colitis-associated cancer in mice.
|
J Clin Invest
|
2011
|
1.23
|
|
15
|
IL23R in the Swedish, Finnish, Hungarian and Italian populations: association with IBD and psoriasis, and linkage to celiac disease.
|
BMC Med Genet
|
2009
|
1.06
|
|
16
|
PepT1 oligopeptide transporter (SLC15A1) gene polymorphism in inflammatory bowel disease.
|
Inflamm Bowel Dis
|
2009
|
1.06
|
|
17
|
Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid-refractory ulcerative colitis: a retrospective observational study.
|
Inflamm Bowel Dis
|
2011
|
1.00
|
|
18
|
Analysis of 39 Crohn's disease risk loci in Swedish inflammatory bowel disease patients.
|
Inflamm Bowel Dis
|
2010
|
0.89
|
|
19
|
Colorectal cancer in patients with inflammatory bowel disease: can we predict risk?
|
World J Gastroenterol
|
2012
|
0.87
|
|
20
|
Initial disease course and treatment in an inflammatory bowel disease inception cohort in Europe: the ECCO-EpiCom cohort.
|
Inflamm Bowel Dis
|
2014
|
0.87
|
|
21
|
Long-term colectomy rate after intensive intravenous corticosteroid therapy for ulcerative colitis prior to the immunosuppressive treatment era.
|
Am J Gastroenterol
|
2006
|
0.86
|
|
22
|
Costs and resource utilization for diagnosis and treatment during the initial year in a European inflammatory bowel disease inception cohort: an ECCO-EpiCom Study.
|
Inflamm Bowel Dis
|
2015
|
0.84
|
|
23
|
Detection of antisynthetic mannoside antibodies (ASigmaMA) reveals heterogeneity in the ASCA response of Crohn's disease patients and contributes to differential diagnosis, stratification, and prediction.
|
Am J Gastroenterol
|
2007
|
0.83
|
|
24
|
Multiple polymorphisms affect expression and function of the neuropeptide S receptor (NPSR1).
|
PLoS One
|
2011
|
0.83
|
|
25
|
Subclinical inflammation with increased neutrophil activity in healthy twin siblings reflect environmental influence in the pathogenesis of inflammatory bowel disease.
|
Inflamm Bowel Dis
|
2013
|
0.83
|
|
26
|
Construction and validation of a web-based epidemiological database for inflammatory bowel diseases in Europe An EpiCom study.
|
J Crohns Colitis
|
2011
|
0.81
|
|
27
|
Eosinophil associated genes in the inflammatory bowel disease 4 region: correlation to inflammatory bowel disease revealed.
|
World J Gastroenterol
|
2012
|
0.80
|
|
28
|
No association between the eczema genes COL29A1 and IL31 and inflammatory bowel disease.
|
Inflamm Bowel Dis
|
2009
|
0.76
|
|
29
|
Polymorphism in the retinoic acid metabolizing enzyme CYP26B1 and the development of Crohn's Disease.
|
PLoS One
|
2013
|
0.75
|
|
30
|
[Current drug therapy in Crohn disease--national guidelines].
|
Lakartidningen
|
2009
|
0.75
|
|
31
|
Erratum: A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitis.
|
Nat Commun
|
2016
|
0.75
|
|
32
|
Clinical Features and HLA Association of 5-Aminosalicylate (5-ASA)-induced Nephrotoxicity in Inflammatory Bowel Disease.
|
J Crohns Colitis
|
2015
|
0.75
|
|
33
|
[The diagnosis of IBD must have a wide foundation].
|
Lakartidningen
|
2009
|
0.75
|